Insights & news

Court of Justice of European Union Creates Questionable Regulatory Shortcut for Parallel Imports of Generic Medicines

  • 05/08/2019
  • Articles

The Court of Justice of the European Union recently issued a puzzling judgment regarding parallel imports of generic medicines. Please find attached a case note discussing the judgment. We also attach a copy of the judgment itself.

Key contacts

Related practice areas

Related insights

Sign up for updates
    • 09/07/2020
    • Articles

    Court of Justice of European Union Is Asked Preliminary Questions on Application of Falsified Medicines

    Attached is a note discussing a German reference for a preliminary ruling seeking clarification from the Court of Justice of the European Union regarding the application of the Falsified Medicines Directive to parallel-traded medicines. A judgment is due in 2021.

    Read more
    • 07/07/2020
    • Articles

    European Medicines Agencies Network Strategy to 2025

    The European Medicines Agency (EMA) and the national competent authorities (NCAs) of the 27 EU Member States in addition to those of Iceland, Liechtenstein and Norway presented on 6 July 2020 a proposed network strategy for tackling healthcare challenges in a rapidly evolving environment (see, attachment). The strategy is supposed to apply until 2025 and stakeholders are invited to submit their comments in response to an online questionnaire by 4 September 2020.

    Read more
    • 02/07/2020
    • Articles

    Healthcare Priorities of German Presidency of EU Council

    The German government assumed yesterday for the latter part of 2020 the rotating Presidency of the Council of the European Union. The policy priorities of that Presidency were spelled out in the attached document entitled “Together for Europe’s recovery”. Not surprisingly, healthcare forms a focal point of these priorities in a number of diverging ways:

    Read more

Subscribe to our updates

Please select the practice areas you are interested in: *